These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 11861292)

  • 21. DNA aneuploidy, increased proliferation and nuclear area of plasma cells in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Leo E; Kropff M; Lindemann A; Steinfurth G; Esselborn H; Rossner R; Adler CP; Böcking A
    Anal Quant Cytol Histol; 1995 Apr; 17(2):113-20. PubMed ID: 7612131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
    Avet-Loiseau H; Facon T; Daviet A; Godon C; Rapp MJ; Harousseau JL; Grosbois B; Bataille R
    Cancer Res; 1999 Sep; 59(18):4546-50. PubMed ID: 10493504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Lacy MQ; Donovan KA; Heimbach JK; Ahmann GJ; Lust JA
    Blood; 1999 Jan; 93(1):300-5. PubMed ID: 9864174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Involvement of LAG-3
    Kreiniz N; Eiza N; Tadmor T; Levy Yurkovski I; Matarasso Greenfeld S; Sabag A; Mubariki R; Suriu C; Votinov E; Toubi E; Vadasz Z
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma.
    Chim CS; Liang R; Leung MH; Kwong YL
    J Clin Pathol; 2007 Jan; 60(1):104-6. PubMed ID: 17213358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
    Mattioli M; Agnelli L; Fabris S; Baldini L; Morabito F; Bicciato S; Verdelli D; Intini D; Nobili L; Cro L; Pruneri G; Callea V; Stelitano C; Maiolo AT; Lombardi L; Neri A
    Oncogene; 2005 Apr; 24(15):2461-73. PubMed ID: 15735737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays.
    Mahtouk K; Moreaux J; Hose D; Rème T; Meissner T; Jourdan M; Rossi JF; Pals ST; Goldschmidt H; Klein B
    BMC Cancer; 2010 May; 10():198. PubMed ID: 20465808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of VARS promotes the growth of multiple myeloma cells by causing imbalance in valine metabolism.
    Shi R; DU W; He Y; Hu J; Yu H; Zhou W; Guo J; Feng X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 48(6):795-808. PubMed ID: 37587064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-mediated regulation in monoclonal gammopathies and myeloma.
    Nair S; Sng J; Boddupalli CS; Seckinger A; Chesi M; Fulciniti M; Zhang L; Rauniyar N; Lopez M; Neparidze N; Parker T; Munshi NC; Sexton R; Barlogie B; Orlowski R; Bergsagel L; Hose D; Flavell RA; Mistry PK; Meffre E; Dhodapkar MV
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
    Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
    Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005).
    Otsuyama K; Asaoku H; Kawano MM
    Int J Hematol; 2006 Jan; 83(1):39-43. PubMed ID: 16443550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathway-based network analysis of myeloma tumors: monoclonal gammopathy of unknown significance, smoldering multiple myeloma, and multiple myeloma.
    Dong L; Chen CY; Ning B; Xu DL; Gao JH; Wang LL; Yan SY; Cheng S
    Genet Mol Res; 2015 Aug; 14(3):9571-84. PubMed ID: 26345890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
    Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
    Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
    Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
    Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation.
    Ely SA; Knowles DM
    Am J Pathol; 2002 Apr; 160(4):1293-9. PubMed ID: 11943714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.
    Hudlebusch HR; Theilgaard-Mönch K; Lodahl M; Johnsen HE; Rasmussen T
    Br J Haematol; 2005 Sep; 130(5):700-8. PubMed ID: 16115125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis.
    Paiva B; Martinez-Lopez J; Corchete LA; Sanchez-Vega B; Rapado I; Puig N; Barrio S; Sanchez ML; Alignani D; Lasa M; García de Coca A; Pardal E; Oriol A; Garcia ME; Escalante F; González-López TJ; Palomera L; Alonso J; Prosper F; Orfao A; Vidriales MB; Mateos MV; Lahuerta JJ; Gutierrez NC; San Miguel JF
    Blood; 2016 Jun; 127(24):3035-9. PubMed ID: 27069257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.
    Martín P; Santón A; García-Cosío M; Bellas C
    Int J Oncol; 2005 Oct; 27(4):1023-8. PubMed ID: 16142319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.
    Pérez-Persona E; Vidriales MB; Mateo G; García-Sanz R; Mateos MV; de Coca AG; Galende J; Martín-Nuñez G; Alonso JM; de Las Heras N; Hernández JM; Martín A; López-Berges C; Orfao A; San Miguel JF
    Blood; 2007 Oct; 110(7):2586-92. PubMed ID: 17576818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.